PTH - Ascendis wins EU backing for hormone replacement therapy
2023-09-14 13:51:53 ET
More on Ascendis
- Seeking Alpha’s Quant Rating on Ascendis Pharma
- Historical earnings data for Ascendis Pharma
- Financial information for Ascendis Pharma
- Ascendis Pharma: Revenue Promise Meets Cash Flow Challenge
- Ascendis Pharma A/S ( ASND ) Q2 2023 Earnings Call Transcript
- Balancing Prospects And Perils: An Analysis Of Ascendis Pharma And Its Innovations
- Ascendis Pharma GAAP EPS of -€2.16, revenue of €47.39M
For further details see:
Ascendis wins EU backing for hormone replacement therapy